McCann Wins $20 Mil. Zicam Brands

Inspiration meets innovation at Brandweek, the ultimate marketing experience. Join industry luminaries, rising talent and strategic experts in Phoenix, Arizona this September 23–26 to assess challenges, develop solutions and create new pathways for growth. Register early to save.

LOS ANGELES Interpublic Group’s McCann Erickson has been assigned creative and media duties for Matrixx Initiatives’ Zicam brands over-the-counter drugs for cold and allergy symptoms, the agency confirmed.

There was no competitive review. Estimated billings are $20 million.

Ian McGregor, executive vice president and general manager of McCann in Los Angeles, said the Phoenix-based pharmaceuticals company especially valued the agency’s strategic thinking and its “holistic approach to ‘demand creation’ using the full range of [McCann] Worldgroup services.”

“We





AW+

WORK SMARTER - LEARN, GROW AND BE INSPIRED.

Subscribe today!

To Read the Full Story Become an Adweek+ Subscriber

View Subscription Options

Already a member? Sign in